Rocket One, Inc. (RKTO)
0.6712
-0.03
(-4.31%)
USD |
NASDAQ |
Oct 07, 16:00
0.6712
0.00 (0.00%)
After-Hours: 16:03
Rocket One Enterprise Value : 8.370M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 8.370M |
| October 05, 2026 | 8.569M |
| October 02, 2026 | 8.284M |
| October 01, 2026 | 8.117M |
| September 30, 2026 | 8.666M |
| September 29, 2026 | 9.068M |
| September 28, 2026 | 9.225M |
| September 25, 2026 | 9.909M |
| September 24, 2026 | 9.728M |
| September 23, 2026 | 9.545M |
| September 22, 2026 | 10.22M |
| September 21, 2026 | 9.466M |
| September 18, 2026 | 10.42M |
| September 17, 2026 | 10.42M |
| September 16, 2026 | 13.02M |
| September 15, 2026 | 9.198M |
| September 14, 2026 | 7.665M |
| September 11, 2026 | 6.960M |
| September 10, 2026 | 7.069M |
| September 09, 2026 | 7.526M |
| September 08, 2026 | 8.235M |
| September 04, 2026 | 8.205M |
| September 03, 2026 | 8.124M |
| September 02, 2026 | 8.138M |
| September 01, 2026 | 7.874M |
| Date | Value |
|---|---|
| August 31, 2026 | 8.048M |
| August 28, 2026 | 8.567M |
| August 27, 2026 | 8.847M |
| August 26, 2026 | 8.917M |
| August 25, 2026 | 9.244M |
| August 24, 2026 | 9.225M |
| August 21, 2026 | 9.390M |
| August 20, 2026 | 9.58M |
| August 19, 2026 | 9.830M |
| August 18, 2026 | 9.782M |
| August 17, 2026 | 9.868M |
| August 14, 2026 | 9.819M |
| August 13, 2026 | 10.05M |
| August 12, 2026 | 10.57M |
| August 11, 2026 | 10.55M |
| August 10, 2026 | 10.43M |
| August 07, 2026 | 9.726M |
| August 06, 2026 | 10.50M |
| August 05, 2026 | 10.65M |
| August 04, 2026 | 11.11M |
| August 03, 2026 | 10.43M |
| July 31, 2026 | 10.67M |
| July 30, 2026 | 10.45M |
| July 29, 2026 | 9.705M |
| July 28, 2026 | 10.19M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.878B |
| Corcept Therapeutics, Inc. | 12.61B |
| Veru, Inc. | 19.01M |
| Johnson & Johnson | 641.85B |
| Eli Lilly & Co. | 1.136T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.835M |
| Total Expenses (Quarterly) | 3.835M |
| EPS Diluted (Quarterly) | -0.1866 |
| Earnings Yield | -123.4% |
| Normalized Earnings Yield | -122.63 |